Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
abeotaxane (2 trials)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (1 total)